Antiviral Therapeutics for Pediatric Primary and Acute Care

1.0 NAPNAP Contact Hour, of which 1.0 is pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non-members, this continuing education activity rate is $20. This course is a record presentation for NAPNAP's 2024 National Conference. 

Viral illness is common in the pediatric population, and antiviral therapies are available for prevention or treatment of select viruses. This presentation will review antiviral medications commonly used in pediatric primary and acute care, including targeted populations, efficacy data and current guidance.

This archived presentation from our 2024 national conference is available as part of a bundle of courses recorded during our 2024 conference in Denver, CO. Purchase the conference bundle to be enrolled in the full library of 2024 conference sessions, and earn up to 27 NAPNAP Contact Hours, 5.5 Pharmacology,1.25 Psychopharmacology and 2.5 Controlled Substance. 

This continuing education activity is offered at a member-only discounted rate of $199, a cost-savings of more than $60. Non-members may purchase this bundle for $500. Great news - You can join NAPNAP before purchasing to save more than $300. To see the complete listing of courses included in the 2024 conference bundle, click here.

Please note that this program is a recording from a live session from NAPNAP 2024 national conference in Denver, CO. If you earned CE for this session, this course will be a duplicate.

IMPORTANT: You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information.    

Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: ce@napnap.org

Copyright 2024 © by National Association of Pediatric Nurse Practitioners

Target Audience

Pediatric-focused advanced practice registered nurses.

Learning Objectives

  • Explore the current landscape of antiviral drugs available for pediatric populations, emphasizing their safety, efficacy and age-specific dosing guidelines.
  • Review common viral infections in pediatric primary and acute care, identifying key targets for antiviral interventions and discussing evidence-based treatment approaches.
  • Evaluate emerging trends and future directions in antiviral therapeutics for pediatric populations.
Course summary
Available credit: 
  • 1.00 Contact hours
Course opens: 
06/27/2024
Course expires: 
06/30/2026
Cost:
$20.00
Part of: 
2024 National Conference on Pediatric Health Care Bundle SAVE
Rating: 
0

Ashley Gyura, DNP, CPNP-PC

There are no disclosures to report.

Available Credit

  • 1.00 Contact hours

Price

Cost:
$20.00
Please login or register to take this course.